Regulated marijuana offers new chance at equity: Q&A with social justice leader Martin Luther King III
Martin Luther King III discusses why the regulated marijuana industry has captured his attention and his hopes for its future.
Rescheduling could change how medical practitioners do business: Q&A with marijuana health pros
Here’s how marijuana rescheduling could impact medical practitioners working in the cannabis space.
Expectations for Minnesota’s adult-use marijuana market: Q&A with women behind state’s legislation
Leili Fatehi and Laura Monn Ginsburg, who helped spearhead Minnesota’s adult-use marijuana legislation, discuss how hemp-derived cannabinoids factor into the impending market and what the state – and the nation – can expect when it launches.
Cannabis MSO Tilt shifts strategy, cuts costs under new leadership: Q&A with interim CEO Tim Conder
In a few short months at the helm, Tilt Holdings interim CEO Tim Conder has initiated significant cost reductions and reevaluated brand partnerships – including cutting ties with some social equity brands – while shifting focus to the cannabis company’s vape hardware business.
US Hemp Roundtable shares goals for 2023 Farm Bill: Q&A with Jonathan Miller
The U.S. Hemp Roundtable and 30 other cannabis organizations submitted a list of nine priorities for the House and Senate committees involved in creating the Farm Bill to consider as they solidify new legislation.
The upside of uplisting cannabis stocks: Q&A with Curaleaf CEO Matt Darin
CEO Matt Darin discusses Curaleaf’s interest in uplisting to a larger stock exchange, recent layoffs and New York’s adult-use cannabis market.
How to build a successful cannabis brand: Q&A with craft alcohol pioneer Rhonda Kallman
Boston Beer Co. and Boston Harbor Distillery’s Rhonda Kallman shares what the cannabis industry can learn from craft beer and spirits.
